Article Search
검색
검색 팝업 닫기

Metrics

Help

  • 1. Aims and Scope

    Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE

  • 2. Editorial Board

    Editor-in-Chief + MORE

    Editor-in-Chief
    Yong Chan Lee Professor of Medicine
    Director, Gastrointestinal Research Laboratory
    Veterans Affairs Medical Center, Univ. California San Francisco
    San Francisco, USA

    Deputy Editor

    Deputy Editor
    Jong Pil Im Seoul National University College of Medicine, Seoul, Korea
    Robert S. Bresalier University of Texas M. D. Anderson Cancer Center, Houston, USA
    Steven H. Itzkowitz Mount Sinai Medical Center, NY, USA
  • 3. Editorial Office
  • 4. Articles
  • 5. Instructions for Authors
  • 6. File Download (PDF version)
  • 7. Ethical Standards
  • 8. Peer Review

    All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
    The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.

    The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.

Search

Search

Year

to

Article Type

Review

Split Viewer

Anxiety, Depression and Quality of Life in Patients with Irritable Bowel Syndrome

Hyun Sun Cho*, Jae Myung Park*, Chul Hyun Lim*, Yu Kyung Cho*, In Seok Lee*, Sang Woo Kim*, Myung-Gyu Choi*, In-Sik Chung*, and Yun Kyung Chung

*Division of Gastroenterology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, and Korean Occupational Safety & Health Agency, Seoul, Korea

Correspondence to:Jae Myung Park

Gut and Liver 2011; 5(1): 29-36

Published online March 30, 2011 https://doi.org/10.5009/gnl.2011.5.1.29

Copyright © Gut and Liver.

Abstract

Background/Aims: There have been few Asian studies regarding anxiety and depression associated with irritable bowel syndrome (IBS). The aim of this study was to evaluate the frequency and importance of anxiety and depression in Korean patients with IBS. Methods: A total of 124 IBS patients and 91 healthy subjects were enrolled consecutively. All participants were asked to complete self-administered questionnaires: one addressing symptom severity, the Short Form 36, and the Hospital Anxiety and Depression Scale (HADS). The patients were also asked to complete the IBS-specifi c quality of life (IBS–OL) questionnaire. Results: Anxiety and depression were observed in 38.6% and 38.6% of IBS patients, respectively, and in 24.2% and 16.5% of healthy subjects, respectively (p<0.05 for both). The mean HADS scores for anxiety and depression in IBS patients were 6.8±4.5 and 7.1±4.4, respectively. Both anxiety and depression were associated with self-reported symptom severity (p<0.012 and p<0.001, respectively). As determined by multivariate analysis, symptom severity was the most important factor in the prediction of anxiety and depression. Self-reported symptom severity and depression were clearly and independently associated with the overall IBS–OL score. Conclusions: Anxiety and depression were frequently observed in Korean IBS patients and were related to the severit of their symptoms and the impairment of the patient' QOL. Our data suggest that assessing anxiety and depression is important when evaluating IBS patients. (Gut Liver 2011;5:29-36)

Keywords: Irritable bowel syndrome, Anxiety, Depression, Quality of life


Article

Review

Gut and Liver 2011; 5(1): 29-36

Published online March 30, 2011 https://doi.org/10.5009/gnl.2011.5.1.29

Copyright © Gut and Liver.

Anxiety, Depression and Quality of Life in Patients with Irritable Bowel Syndrome

Hyun Sun Cho*, Jae Myung Park*, Chul Hyun Lim*, Yu Kyung Cho*, In Seok Lee*, Sang Woo Kim*, Myung-Gyu Choi*, In-Sik Chung*, and Yun Kyung Chung

*Division of Gastroenterology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, and Korean Occupational Safety & Health Agency, Seoul, Korea

Correspondence to:Jae Myung Park

Abstract

Background/Aims: There have been few Asian studies regarding anxiety and depression associated with irritable bowel syndrome (IBS). The aim of this study was to evaluate the frequency and importance of anxiety and depression in Korean patients with IBS. Methods: A total of 124 IBS patients and 91 healthy subjects were enrolled consecutively. All participants were asked to complete self-administered questionnaires: one addressing symptom severity, the Short Form 36, and the Hospital Anxiety and Depression Scale (HADS). The patients were also asked to complete the IBS-specifi c quality of life (IBS–OL) questionnaire. Results: Anxiety and depression were observed in 38.6% and 38.6% of IBS patients, respectively, and in 24.2% and 16.5% of healthy subjects, respectively (p<0.05 for both). The mean HADS scores for anxiety and depression in IBS patients were 6.8±4.5 and 7.1±4.4, respectively. Both anxiety and depression were associated with self-reported symptom severity (p<0.012 and p<0.001, respectively). As determined by multivariate analysis, symptom severity was the most important factor in the prediction of anxiety and depression. Self-reported symptom severity and depression were clearly and independently associated with the overall IBS–OL score. Conclusions: Anxiety and depression were frequently observed in Korean IBS patients and were related to the severit of their symptoms and the impairment of the patient' QOL. Our data suggest that assessing anxiety and depression is important when evaluating IBS patients. (Gut Liver 2011;5:29-36)

Keywords: Irritable bowel syndrome, Anxiety, Depression, Quality of life

Gut and Liver

Vol.15 No.5
September, 2021

pISSN 1976-2283
eISSN 2005-1212

qrcode
qrcode

Share this article on :

  • line

Popular Keywords

Gut and LiverQR code Download
qr-code

Editorial Office